OrthAlign received FDA 510(k) clearance to market UniAlign™, a handheld, single-use navigation device for Unicompartmental Knee Arthroplasty (UKA). Product launch is slated for mid- to late-Summer 2016.
UniAlign establishes the mechanical axis of the tibia, determining the varus/valgus angle and the posterior slope angle of the cutting block relative to the tibia, for the transverse resection. It is open platform, and requires no pre-op imaging or custom cutting guides.
UniAlign is based on the company’s KneeAlign® technology that has been used in >40,000 TKAs worldwide, to date.
OrthAlign received FDA 510(k) clearance to market UniAlign™, a handheld, single-use navigation device for Unicompartmental Knee Arthroplasty (UKA). Product launch is slated for mid- to late-Summer 2016.
UniAlign establishes the mechanical axis of the tibia, determining the varus/valgus angle and the posterior slope angle of the cutting block...
OrthAlign received FDA 510(k) clearance to market UniAlign™, a handheld, single-use navigation device for Unicompartmental Knee Arthroplasty (UKA). Product launch is slated for mid- to late-Summer 2016.
UniAlign establishes the mechanical axis of the tibia, determining the varus/valgus angle and the posterior slope angle of the cutting block relative to the tibia, for the transverse resection. It is open platform, and requires no pre-op imaging or custom cutting guides.
UniAlign is based on the company’s KneeAlign® technology that has been used in >40,000 TKAs worldwide, to date.
Copy to clipboard 
